Naproxen Delayed Release and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Naproxen Delayed Release and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: naproxen
Brand name: Aleve, EC-Naprosyn, Flanax Pain Reliever, Midol Extended Relief, Naprelan, Naprosyn, Anaprox, Anaprox-DS, Naproxen Sodium, Aleve Caplet, Aleve Gelcap, Aleve Easy Open Arthritis, Naprelan 375, Naprelan 500, Flanax
Synonyms: Naproxen
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Naproxen Delayed Release-Tilia Fe
- Naproxen Delayed Release-Tiludronate
- Naproxen Delayed Release-Timentin
- Naproxen Delayed Release-Timentin Add-Vantage
- Naproxen Delayed Release-Timentin Injection
- Naproxen Delayed Release-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Naproxen Modified-Release Tablets
- Tildrakizumab-asmn Subcutaneous-Naproxen Sodium
- Tildrakizumab-asmn Subcutaneous-Naproxen Suspension
- Tildrakizumab-asmn Subcutaneous-Naproxen Tablets
- Tildrakizumab-asmn Subcutaneous-Naproxen Tablets and Capsules
- Tildrakizumab-asmn Subcutaneous-Naratriptan